Showing results (101-110 of 224) with videos related to
Sort By:
Pageof 23
Journal of Pediatric Surgery|July 22, 2018
Incidence and risk factors for sepsis after childhood splenectomyArin L Madenci, Lindsey B Armstrong, Nicollette K Kwon, et al.Plos One|May 30, 2013
Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST]Lorna Kelly, Kenneth Bryan, Su Young Kim, et al.Journal of Pediatric Surgery|June 21, 2011
Adrenal cortical tumors in children: factors associated with poor outcomeJustin D Klein, Christopher G Turner, Fabienne L Gray, et al.Pediatric Blood & Cancer|August 19, 2023
Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumorsAndrew Groves, Abigail Ward, Yvonne Y Li, et al.Pediatric Blood & Cancer|December 19, 2017
Response Evaluation Criteria in Solid Tumors (RECIST) following neoadjuvant chemotherapy in osteosarcomaLillian M Guenther, R Grant Rowe, Patricia T Acharya, et al.JCO Precision Oncology|January 4, 2019
Rationale and Design of the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyPam K Mangat, Susan Halabi, Suanna S Bruinooge, et al.European Journal of Cancer (Oxford, England : 1990)|October 7, 2019
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology GroupLisa M Kopp, Suman Malempati, Mark Krailo, et al.Pediatric Surgery International|March 30, 2018
Testicular atrophy following inguinal hernia repair in childrenKristin A Sonderman, Lindsey L Wolf, Lindsey B Armstrong, et al.Journal of Pediatric Surgery|April 25, 2018
Hernia recurrence following inguinal hernia repair in childrenKathryn Taylor, Kristin A Sonderman, Lindsey L Wolf, et al.Pediatric Blood & Cancer|April 30, 2016
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor CommitteeMichael W Bishop, Yu-Chen Chang, Mark D Krailo, et al.Pageof 23